Publication | Open Access

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation

Functional Gastrointestinal DisorderGastrointestinal PharmacologyMedicineGastroenterologyVivo EfficacyClinical GastroenterologyPharmacotherapyOral PharmacokineticsChronic Idiopathic ConstipationPharmacologyDrug Discovery